← Eichor
Study identifier: NCT07060144 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cognitive Processing Therapy (CPT) for Perinatal Posttraumatic Stress Disorder (PTSD)

Condition: Posttraumatic Stress Disorder (PTSD) · Pregnancy  ·  Sponsor: University of Texas at Austin

PhaseNA
Planned participants60
Who can joinFemale, 18 Years to 46 Years
Healthy volunteersNo

About this study

Pregnant women with a primary diagnosis of posttraumatic stress disorder (PTSD) (PTSD Checklist for DSM-5 (PCL-5) score \> 33) will be randomized to receive conventional cognitive processing therapy (CPT) (60-min session once/week for 12 weeks) or massed CPT (mCPT) (an intensive schedule of 12 60-min sessions over 5 days, approximately 2-3 sessions per day) via telemedicine, for treatment of PTSD. The research aims will be three-fold: (1) Evaluate the relative efficacy and tolerability of CPT vs. mCPT for treatment of perinatal PTSD and depression; (2) Determine the effect of CPT upon maternal-infant attachment and interaction; (3) Collect pilot data of obstetric and neonatal outcomes among those receiving the two CPT delivery schedules.

This description comes directly from the study's public registry record.

Talk to the study team

Research Associate I  ·  512-766-6209  ·  ambreen.rana@austin.utexas.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Texas at Austin, Dell Medical School, Department of PsychiatryAustin, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07060144